Sandoz Tries Again With US Pegfilgrastim

 
• By Dave Wallace

Sandoz has resubmitted its application for biosimilar pegfilgrastim to the FDA, having been knocked back with a complete response letter in 2016.

TryAgain
Sandoz Is Making Another Attempt With Its US Pegfilgrastim Biosimilar • Source: Shutterstock

More from Biosimilars

More from Products